TWO SIGMA INVESTMENTS, LP - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 19 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,384,000
+141.1%
97,400
+37.4%
0.01%
+66.7%
Q2 2020$574,000
+8100.0%
70,900
+193.7%
0.00%
Q3 2019$7,000
-22.2%
24,138
-8.7%
0.00%
Q2 2019$9,000
-74.3%
26,438
-50.8%
0.00%
Q1 2019$35,0000.0%53,728
+164.7%
0.00%
Q4 2018$35,00020,3000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
VR Adviser, LLC 4,040,000$59,428,0008.74%
Fairmount Funds Management LLC 1,478,181$21,744,0007.78%
COMMODORE CAPITAL LP 852,871$12,546,0006.82%
Ghost Tree Capital, LLC 1,950,000$28,685,0006.39%
Endurant Capital Management LP 655,741$9,646,0003.48%
FRAZIER MANAGEMENT LLC 3,053,107$44,879,0003.46%
ACUTA CAPITAL PARTNERS, LLC 803,000$11,812,0003.21%
NEA Management Company, LLC 5,736,363$84,382,0002.23%
Tri Locum Partners LP 296,838$4,366,0001.59%
Avidity Partners Management LP 3,185,200$46,854,0001.52%
View complete list of TRILLIUM THERAPEUTICS INC shareholders